Eric Ariazi is a results-oriented executive with over 25 years of experience in translational research and diagnostics. He is the Director of IVD Assay Development at Universal Diagnostics, focusing on blood-based cancer screening. His expertise spans epigenomics, precision oncology, and NGS assay development, with a Ph.D. from the University of Wisconsin-Madison.
Outside of his primary professional focus, Eric has a demonstrated interest in programming, having earned a certificate in Python. He actively engages with the scientific community by attending and speaking at industry summits and webinars, sharing his insights on biomarker development and new diagnostic technologies.
He holds a patent for implementing machine learning in the development and testing of multi-analyte assays for cancer diagnostics.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.